{"id":39477,"date":"2023-04-07T15:48:12","date_gmt":"2023-04-07T19:48:12","guid":{"rendered":"https:\/\/nebula.org\/blog\/?p=39477"},"modified":"2023-05-30T09:25:37","modified_gmt":"2023-05-30T13:25:37","slug":"low-cetp-levels-reduced-hypertension","status":"publish","type":"post","link":"https:\/\/nebula.org\/blog\/low-cetp-levels-reduced-hypertension\/","title":{"rendered":"Low CETP levels linked to reduced hypertension"},"content":{"rendered":"\n

Hypertension, or chronically high blood pressure<\/a>, is a widespread condition that forces the heart to work harder to pump blood through the arteries. Doctors typically assess blood pressure during annual medical check-ups, but those at higher risk may require more frequent monitoring. Left untreated, hypertension can lead to heart attacks<\/a>, strokes<\/a>, and other severe health issues. Did you know that low CETP levels may be linked to reduced hypertension?<\/p>\n\n\n\n

Often, individuals are unaware of their high blood pressure until damage has occurred. Symptoms can include headaches, nausea, dizziness, nosebleeds, fatigue, and insomnia<\/a>.<\/p>\n\n\n\n

Doctors usually recommend lifestyle adjustments as the initial treatment for hypertension. A heart-healthy diet low in salt, regular exercise, and maintaining a healthy weight can help reduce blood pressure. If these changes prove insufficient, doctors may prescribe medications such as angiotensin-converting enzyme (ACE) inhibitors, Angiotensin II receptor blockers (ARBs), and calcium channel blockers.<\/p>\n\n\n\n

\"Heart
Heart image. Photo by Robina Weermeijer<\/a> on Unsplash<\/a>.<\/figcaption><\/figure>\n\n\n\n

Several factors contribute to an increased risk of hypertension, including age, race, family history, obesity<\/a>, smoking, stress, and other chronic conditions. Genetics may also play a role.<\/p>\n\n\n\n

A recent study published in Mayo Clinic Proceedings<\/em><\/a> suggests that a genotype associated with reduced CETP levels may contribute to a lower prevalence of hypertension.<\/p>\n\n\n\n

The Study<\/h2>\n\n\n\n

The study built upon earlier research<\/a> demonstrating that individuals with a specific mutation in the CETP gene (I405V) had decreased CETP levels and lived longer.<\/p>\n\n\n\n

The study involved 521 participants from the \u201cSearching for Longevity Genes in the Historically Unique Ashkenazi Jewish Population Study\u201d, divided into three groups: centenarians, their offspring, and controls. Researchers measured hypertension and CETP levels, defining hypertension as:<\/p>\n\n\n\n